Vaccine development

Analysis and Comment (4)

Zrzz2zzx-1351641925
Scientists worked with Hendra virus at the highest level of biosafety within CSIRO’s Australian Animal Health Laboratory. CSIRO

How we developed the Hendra virus vaccine for horses

By Deborah Middleton, CSIRO

Today we are launching Equivac® HeV, the world’s first commercially available Hendra vaccine for horses. This breakthrough is the culmination of a scientific journey that dates back to the emergence of…
7qzxqgc6-1332922166
Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus

HIV bolts past immune defences despite humble beginnings

By Jack da Silva

Despite three decades of research, an HIV vaccine remains elusive. The main reason for this is the virus’s uncanny ability to evolve resistance to immune control, so understanding how the virus adapts…
Mvn246x9-1327880405
Up to one million Africa children die of malaria every year. US Army Africa

Genetically modifying parasites to find the best malaria vaccine

By Julie Healer, Walter and Eliza Hall Institute

The great burden of death and disease caused by the malaria parasite often goes unnoticed in the developed world. But it’s the leading cause of death in children under five years old in many sub-Sahara…
Aapone-20010516000019729935-hepatitis_c-original
In the developed world, people who regularly inject drugs are most at risk of being infected with hepatitis C. AAP

Repeat offender: the strange comings and goings of hepatitis C

By Peter Higgs, Burnet Institute

Hepatitis C is a blood-borne virus that infects about 3% of the world’s population. It’s a significant cause of both illness and death due to cirrhosis (advanced liver scarring) and liver cancer. By the…

Research and News (1)

Research Briefs (2)

Participants (15)